Q3 2018 Conference calls for the media and for analysts

• Healthcare and Life Science deliver very strong organic sales growth, Performance Materials reports moderate sales growth
• Foreign exchange effects (–9.5%) lead to a significant decline of –5.9% in Group EBITDA pre
• Forecast for organic EBITDA pre development for full year 2018 confirmed

“2018 was a challenging year for our company. We made future-oriented decisions that will lead to profitable growth as of 2019,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. “In the third quarter, we generated strong organic sales growth across all three business sectors. In particular, Healthcare and Life Science performed well, delivering strong organic growth of nearly 10 percent.”
(Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany)

Conference Calls

• Conference call for the media (9:30 a.m. CET)
• Conference call for analysts (2 p.m. CET)

Downloads

• Quarterly report Q3/2018 (PDF)
• Related news
• Presentation for the media (PDF)
• Presentation for analysts (PDF)
• Summary (PDF)
• Overview of the financial figures (XLS)
  
• Regional sector sales (XLS)
• Digital press kit (ZIP File)
  

Social Media

• twitter.com/hashtag/EMD2018Q3